Scientists have discovered how bacteria utilize the CRISPR system to build immunity against viruses, similar to a vaccine. This research could lead to improved phage therapies and combat antimicrobial resistance.
The concept of a single-celled bacterium possessing a defense system akin to the complex human immune system, comprising 1.8 trillion cells, continues to astonish molecular biologist Joshua Modell of Johns Hopkins University. Two decades ago, scientists unveiled the existence of CRISPR , an adaptive defense mechanism employed by bacteria.
This remarkable system empowers these microbes to identify and neutralize viral invaders upon subsequent encounters, a feat previously thought exclusive to more complex organisms. A recent study, published in Scientific American, delves into this bacterial defense strategy, offering insights that may pave the way for innovative treatments to combat antimicrobial resistance, a significant contributor to millions of fatalities each year. The CRISPR system works by enabling bacteria to edit their own genomes. Following exposure to a virus, bacteria employ a specialized enzyme to integrate small fragments of the virus's DNA, known as spacers, into their own genome. This strategic incorporation allows the bacteria to recognize and effectively combat the virus during future invasions. Scientists are actively utilizing this enzymatic tool, often referred to as molecular scissors, in diverse applications ranging from laboratory experiments to gene therapies, yet a comprehensive understanding of the process within bacteria remained elusive. Modell aptly summarizes this knowledge gap, characterizing it as the CRISPR mystery, highlighting the incomplete comprehension of the intricate mechanisms at play within the bacterial cell.\To unravel the complexities of how bacteria capture and incorporate viral DNA, the researchers meticulously conducted controlled laboratory experiments involving bacteria and the specific viruses, called phages, that infect them. During the infectious phase, phages typically induce immediate cell rupture, a process known as lysis. However, on rare occasions, phages can enter a dormant state, hiding within the bacterial DNA in a phase known as lysogeny, a condition that poses considerable challenges to scientific investigation. The research team, led by Modell, infected bacteria with phages capable of both active and dormant states, including genetically engineered phages that were permanently locked in an active state. Subsequently, the team collected surviving cells and analyzed their genetic code, meticulously searching for the addition of new spacers derived from the viral DNA. The findings revealed a crucial correlation: bacteria only integrated spacers from phages that had the capacity to enter the dormant lysogenic state. According to Modell, during this quiescent period, bacteria have sufficient time to acquire small segments of viral DNA and store them in their genome. He draws an insightful analogy, comparing the CRISPR system's memory creation to that of a vaccine, as it targets an inactivated form of the virus. To validate their findings, Modell and his team exposed bacteria carrying these acquired spacers to the same phages once more, observing whether these newly formed genetic memories conferred protection against infection. The results demonstrated that the bacteria, armed with these stored viral fragments, could successfully identify and fend off the phages. Molecular biologist Stan Brouns of Delft University of Technology in the Netherlands, who was not involved in the study, hailed the findings as remarkable.\The implications of this research extend to the field of phage therapy, an approach that utilizes viruses to treat bacterial infections that have become resistant to antibiotics. Understanding the intricacies of phage-bacterial interactions is paramount to improving the effectiveness of these therapies. Furthermore, the new insights gained from this study may contribute to the design of phages that are capable of targeting a wider range of infection-causing bacteria. Rodolphe Barrangou, a molecular biologist from North Carolina State University and a co-founder of Locus Biosciences, a biotech company focused on developing antibacterial products, highlights the significance of this research. He noted that there are many different types of defence mechanisms, the study provides insights for the scientists to tackle the diseases. The insights gained are expected to be helpful for the development of phage therapies across different diseases. Scientific American has consistently championed the cause of science and industry for nearly two centuries, and its role is arguably more crucial than ever. Support from subscribers helps ensure the continued publication of impactful stories on discoveries and ideas shaping our world. By supporting the publication, readers can contribute to research, report and support scientists, particularly in a climate where the importance of science is often understated
CRISPR Bacteria Viruses Phages Antimicrobial Resistance Immune System Phage Therapy Bacterial Defense Genetics Molecular Biology
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Leesa Manion’s fury exposes a broken system in King County’s justice systemAward-winning broadcast journalist with 30+ years of experience covering stories that impact Washington — from major investigations to regional news.
Read more »
Ripple CEO Breaks Silence on Upcoming Financial System Shake-Up: DetailsThis comes as massive $1 trillion inflow predicted for stablecoins ahead
Read more »
Water fingerprint found on comet older than our solar system, study revealsThe interstellar object 3I/ATLAS is thought to be roughly 7 billion years old, making it even older than our solar system.
Read more »
Kerrisdale Capital Opens Short on Ether Treasury Stock BMNRThe company's model mimics a failing playbook and lacks transparency and leadership appeal, said Kerrisdale.
Read more »
Why everything you thought you knew about your immune system is wrongImmunologist Daniel Davis wants to eradicate long-held myths and replace them with wonder at the complexity of the body’s defence system
Read more »
UC Santa Barbara develops new soft robotic system for emergency intubation proceduresFox News Channel offers its audiences in-depth news reporting, along with opinion and analysis encompassing the principles of free people, free markets and diversity of thought, as an alternative to the left-of-center offerings of the news marketplace.
Read more »